Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 145 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Lenalidomide in addition to R-CHOP chemotherapy for diffuse large B-cell lymphoma	Lenalidomide (Revlimid) , R-CHOP	Diffuse large B-cell lymphoma (DLBCL)	Haematological Cancer and Lymphomas	2019	View \| Download
Lacosamide for primary generalised tonic-clonic seizures – adjunctive therapy	Lacosamide (Vimpat)	Epilepsy	Neurology	2019	View \| Download
Ixazomib citrate for newly diagnosed multiple myeloma inelgible for autologous stem cell transplant– maintenance therapy	Ixazomib (Ninlaro; MLN 9708; MLN 2238; ixazomib citrate)	Multiple myeloma (MM)	Haematological Cancer and Lymphomas	2019	View \| Download
Isatuximab in addition to carfilzomib and dexamethasone for relapsed and/or refractory multiple myeloma	Carfilzomib (Kyprolis; ONO-7057) , Dexamethasone (dexamethasone sodium metasulfobenzoate) , Isatuximab (SAR650984; Sarclisa)	Multiple myeloma (MM)	Haematological Cancer and Lymphomas	2019	View \| Download
Inclisiran for primary hypercholesterolaemia and mixed dyslipidaemia	Inclisiran (ALN-PCSsc; ALN-60212)	Heterozygous familial hypercholesterolaemia (HeFH) , Primary hypercholesterolaemia	Endocrine Nutritional and Metabolic Disorders , Genetic Disorders	2019	View \| Download
Imlifidase for kidney transplantation in highly sensitised patients with chronic kidney disease	Imlifidase (IdeS)	Chronic kidney disease (CKD)	Cardiovascular System , Nephrology	2019	View \| Download
Idasanutlin in addition to cytarabine for relapsed or refractory acute myeloid leukaemia	Cytarabine , Idasanutlin (RG7388; RO5503781)	Acute myeloid leukaemia (AML)	Haematological Cancer and Lymphomas	2019	View \| Download
Ibrutinib in addition to rituximab for chronic lymphocytic leukaemia – first-line	Ibrutinib (Imbruvica)	Chronic lymphocytic leukaemia (CLL)	Haematological Cancer and Lymphomas	2019	View \| Download
Ibalizumab in combination with other antiretroviral(s) for multidrug-resistant HIV-1 infection	Ibalizumab (Trogarzo; TNX-355)	HIV infection	Infectious Disease	2019	View \| Download
Human acellular vessel for vascular access for haemodialysis in end-stage renal disease	Human Acellular Vessel (HumaGraft; Humacyl)	Arterial venous access	Cardiovascular System	2019	View \| Download